5-[3-butan-2-yl-8-[2-(4-methylphenyl)ethylamino]imidazo[1,2-a]pyridin-6-yl]pyridine-3-carbonitrile
C26H27N5 — CID 146522453
Data last refreshed: (MolForge compound catalog, from PubChem)
About 5-[3-butan-2-yl-8-[2-(4-methylphenyl)ethylamino]imidazo[1,2-a]pyridin-6-yl]pyridine-3-carbonitrile
5-[3-butan-2-yl-8-[2-(4-methylphenyl)ethylamino]imidazo[1,2-a]pyridin-6-yl]pyridine-3-carbonitrile (PubChem CID 146522453) has the molecular formula C26H27N5 and a molecular weight of 409.54 g/mol. Its IUPAC name is 5-[3-butan-2-yl-8-[2-(4-methylphenyl)ethylamino]imidazo[1,2-a]pyridin-6-yl]pyridine-3-carbonitrile.
Molecular Properties
| Compound Name | 5-[3-butan-2-yl-8-[2-(4-methylphenyl)ethylamino]imidazo[1,2-a]pyridin-6-yl]pyridine-3-carbonitrile |
|---|---|
| PubChem CID | 146522453 |
| Molecular Formula | C26H27N5 |
| Molecular Weight | 409.54 g/mol |
| Exact Mass | 409.23 |
| IUPAC Name | 5-[3-butan-2-yl-8-[2-(4-methylphenyl)ethylamino]imidazo[1,2-a]pyridin-6-yl]pyridine-3-carbonitrile |
| SMILES | CCC(C)c1cnc2c(NCCc3ccc(C)cc3)cc(-c3cncc(C#N)c3)cn12 |
| InChI | InChI=1S/C26H27N5/c1-4-19(3)25-16-30-26-24(29-10-9-20-7-5-18(2)6-8-20)12-23(17-31(25)26)22-11-21(13-27)14-28-15-22/h5-8,11-12,14-17,19,29H,4,9-10H2,1-3H3 |
| InChIKey | HBKAYTXJQGXFKF-UHFFFAOYSA-N |
| XLogP | 5.74 |
| TPSA | 66.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 31 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 409.54 |
| LogP ≤ 5 | 5.74 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 146522453 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.